0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cholera Vaccine (Oral Route) - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-12G8076
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Cholera Vaccine Oral Route Market Insights and Forecast to 2028
BUY CHAPTERS

Cholera Vaccine (Oral Route) - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-12G8076
Report
November 2023
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cholera Vaccine (Oral Route) - Market Size

The global Cholera Vaccine (Oral Route) market size is expected to reach US$ 1525.6 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029.

Cholera Vaccine (Oral Route) -  Market

Cholera Vaccine (Oral Route) - Market

The market is mainly driven by the significant applications of Cholera Vaccine (Oral Route) in various end use industries. The expanding demands from the Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies and Others, are propelling Cholera Vaccine (Oral Route) market. Shanchol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dukoral segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cholera Vaccine (Oral Route), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Cholera Vaccine (Oral Route) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cholera Vaccine (Oral Route) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cholera Vaccine (Oral Route) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cholera Vaccine (Oral Route) covered in this report include PaxVax, Sanofi, Valneva and EuBiologics, etc.
The global Cholera Vaccine (Oral Route) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PaxVax
Sanofi
Valneva
EuBiologics

Scope of Cholera Vaccine (Oral Route) - Market Report

Report Metric Details
Report Name Cholera Vaccine (Oral Route) - Market
Forecasted market size in 2029 US$ 1525.6 million
CAGR 5.8%
Forecasted years 2023 - 2029
Global Cholera Vaccine (Oral Route) market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cholera Vaccine (Oral Route) market, Segment by Type:
  • Shanchol
  • Dukoral
  • Vaxchora
  • Others
Global Cholera Vaccine (Oral Route) market, by Application
  • Hospital
  • Research & Academic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Cholera Vaccine (Oral Route) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Cholera Vaccine (Oral Route) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Cholera Vaccine (Oral Route) - Market size in 2029?

Ans: The Cholera Vaccine (Oral Route) - Market size in 2029 will be US$ 1525.6 million.

What are the Application segmentation covered in the Cholera Vaccine (Oral Route) - Market report?

Ans: The Applications covered in the Cholera Vaccine (Oral Route) - Market report are Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others

What are the Type segmentation covered in the Cholera Vaccine (Oral Route) - Market report?

Ans: The Types covered in the Cholera Vaccine (Oral Route) - Market report are Shanchol, Dukoral, Vaxchora, Others

1 Cholera Vaccine (Oral Route) Market Overview
1.1 Cholera Vaccine (Oral Route) Product Overview
1.2 Cholera Vaccine (Oral Route) Market Segment by Type
1.2.1 Shanchol
1.2.2 Dukoral
1.2.3 Vaxchora
1.2.4 Others
1.3 Global Cholera Vaccine (Oral Route) Market Size by Type
1.3.1 Global Cholera Vaccine (Oral Route) Market Size Overview by Type (2018-2029)
1.3.2 Global Cholera Vaccine (Oral Route) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
2 Global Cholera Vaccine (Oral Route) Market Competition by Company
2.1 Global Top Players by Cholera Vaccine (Oral Route) Sales (2018-2023)
2.2 Global Top Players by Cholera Vaccine (Oral Route) Revenue (2018-2023)
2.3 Global Top Players by Cholera Vaccine (Oral Route) Price (2018-2023)
2.4 Global Top Manufacturers Cholera Vaccine (Oral Route) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cholera Vaccine (Oral Route) Market Competitive Situation and Trends
2.5.1 Cholera Vaccine (Oral Route) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cholera Vaccine (Oral Route) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cholera Vaccine (Oral Route) as of 2022)
2.7 Date of Key Manufacturers Enter into Cholera Vaccine (Oral Route) Market
2.8 Key Manufacturers Cholera Vaccine (Oral Route) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cholera Vaccine (Oral Route) Status and Outlook by Region
3.1 Global Cholera Vaccine (Oral Route) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cholera Vaccine (Oral Route) Historic Market Size by Region
3.2.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2018-2023)
3.2.2 Global Cholera Vaccine (Oral Route) Sales in Value by Region (2018-2023)
3.2.3 Global Cholera Vaccine (Oral Route) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Region
3.3.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2024-2029)
3.3.2 Global Cholera Vaccine (Oral Route) Sales in Value by Region (2024-2029)
3.3.3 Global Cholera Vaccine (Oral Route) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cholera Vaccine (Oral Route) by Application
4.1 Cholera Vaccine (Oral Route) Market Segment by Application
4.1.1 Hospital
4.1.2 Research & Academic Laboratories
4.1.3 Pharmaceutical & Biotechnology Companies
4.1.4 Others
4.2 Global Cholera Vaccine (Oral Route) Market Size by Application
4.2.1 Global Cholera Vaccine (Oral Route) Market Size Overview by Application (2018-2029)
4.2.2 Global Cholera Vaccine (Oral Route) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
5 North America Cholera Vaccine (Oral Route) by Country
5.1 North America Cholera Vaccine (Oral Route) Historic Market Size by Country
5.1.1 North America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2023)
5.1.3 North America Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2023)
5.2 North America Cholera Vaccine (Oral Route) Forecasted Market Size by Country
5.2.1 North America Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2029)
5.2.2 North America Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2029)
6 Europe Cholera Vaccine (Oral Route) by Country
6.1 Europe Cholera Vaccine (Oral Route) Historic Market Size by Country
6.1.1 Europe Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2023)
6.1.3 Europe Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2023)
6.2 Europe Cholera Vaccine (Oral Route) Forecasted Market Size by Country
6.2.1 Europe Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2029)
6.2.2 Europe Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2029)
7 Asia-Pacific Cholera Vaccine (Oral Route) by Region
7.1 Asia-Pacific Cholera Vaccine (Oral Route) Historic Market Size by Region
7.1.1 Asia-Pacific Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cholera Vaccine (Oral Route) Forecasted Market Size by Region
7.2.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Value by Region (2024-2029)
8 Latin America Cholera Vaccine (Oral Route) by Country
8.1 Latin America Cholera Vaccine (Oral Route) Historic Market Size by Country
8.1.1 Latin America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2023)
8.2 Latin America Cholera Vaccine (Oral Route) Forecasted Market Size by Country
8.2.1 Latin America Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2029)
9 Middle East and Africa Cholera Vaccine (Oral Route) by Country
9.1 Middle East and Africa Cholera Vaccine (Oral Route) Historic Market Size by Country
9.1.1 Middle East and Africa Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cholera Vaccine (Oral Route) Forecasted Market Size by Country
9.2.1 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 PaxVax
10.1.1 PaxVax Company Information
10.1.2 PaxVax Introduction and Business Overview
10.1.3 PaxVax Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 PaxVax Cholera Vaccine (Oral Route) Products Offered
10.1.5 PaxVax Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Cholera Vaccine (Oral Route) Products Offered
10.2.5 Sanofi Recent Development
10.3 Valneva
10.3.1 Valneva Company Information
10.3.2 Valneva Introduction and Business Overview
10.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Valneva Cholera Vaccine (Oral Route) Products Offered
10.3.5 Valneva Recent Development
10.4 EuBiologics
10.4.1 EuBiologics Company Information
10.4.2 EuBiologics Introduction and Business Overview
10.4.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 EuBiologics Cholera Vaccine (Oral Route) Products Offered
10.4.5 EuBiologics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cholera Vaccine (Oral Route) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cholera Vaccine (Oral Route) Industrial Chain Analysis
11.4 Cholera Vaccine (Oral Route) Market Dynamics
11.4.1 Cholera Vaccine (Oral Route) Industry Trends
11.4.2 Cholera Vaccine (Oral Route) Market Drivers
11.4.3 Cholera Vaccine (Oral Route) Market Challenges
11.4.4 Cholera Vaccine (Oral Route) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cholera Vaccine (Oral Route) Distributors
12.3 Cholera Vaccine (Oral Route) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of Shanchol
    Table 2. Major Company of Dukoral
    Table 3. Major Company of Vaxchora
    Table 4. Major Company of Others
    Table 5. Global Cholera Vaccine (Oral Route) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (K Units)
    Table 7. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type (2018-2023)
    Table 8. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US& Million)
    Table 9. Global Cholera Vaccine (Oral Route) Market Share in Value by Type (2018-2023)
    Table 10. Global Cholera Vaccine (Oral Route) Price by Type (2018-2023) & (USD/Unit)
    Table 11. Global Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (K Units)
    Table 12. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type (2024-2029)
    Table 13. Global Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (US$ Million)
    Table 14. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Type (2024-2029)
    Table 15. Global Cholera Vaccine (Oral Route) Price by Type (2024-2029) & (USD/Unit)
    Table 16. North America Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (K Units)
    Table 17. North America Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
    Table 18. Europe Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2023)
    Table 19. Europe Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
    Table 20. Asia-Pacific Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2023)
    Table 21. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
    Table 22. Latin America Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2023)
    Table 23. Latin America Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
    Table 24. Middle East and Africa Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2023)
    Table 25. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
    Table 26. Global Cholera Vaccine (Oral Route) Sales by Company (2018-2023) & (K Units)
    Table 27. Global Cholera Vaccine (Oral Route) Sales Share by Company (2018-2023)
    Table 28. Global Cholera Vaccine (Oral Route) Revenue by Company (2018-2023) & (US$ Million)
    Table 29. Global Cholera Vaccine (Oral Route) Revenue Share by Company (2018-2023)
    Table 30. Global Market Cholera Vaccine (Oral Route) Price by Company (2018-2023) & (USD/Unit)
    Table 31. Global Cholera Vaccine (Oral Route) Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 32. Global Cholera Vaccine (Oral Route) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cholera Vaccine (Oral Route) as of 2022)
    Table 34. Date of Key Manufacturers Enter into Cholera Vaccine (Oral Route) Market
    Table 35. Key Manufacturers Cholera Vaccine (Oral Route) Product Type
    Table 36. Mergers & Acquisitions, Expansion Plans
    Table 37. Global Cholera Vaccine (Oral Route) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Global Cholera Vaccine (Oral Route) Sales by Region (2018-2023) & (K Units)
    Table 39. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2018-2023)
    Table 40. Global Cholera Vaccine (Oral Route) Sales by Region (2018-2023) & (US$ Million)
    Table 41. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2018-2023)
    Table 42. Global Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 43. Global Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (K Units)
    Table 44. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2024-2029)
    Table 45. Global Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (US$ Million)
    Table 46. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2024-2029)
    Table 47. Global Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 48. Global Cholera Vaccine (Oral Route) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 49. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (K Units)
    Table 50. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application (2018-2023)
    Table 51. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
    Table 52. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Application (2018-2023)
    Table 53. Global Cholera Vaccine (Oral Route) Price by Application (2018-2023) & (USD/Unit)
    Table 54. Global Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (K Units)
    Table 55. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application (2024-2029)
    Table 56. Global Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (US$ Million)
    Table 57. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Application (2024-2029)
    Table 58. Global Cholera Vaccine (Oral Route) Price by Application (2024-2029) & (USD/Unit)
    Table 59. North America Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
    Table 60. North America Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
    Table 61. Europe Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
    Table 62. Europe Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
    Table 63. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
    Table 64. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
    Table 65. Latin America Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
    Table 66. Latin America Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
    Table 67. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
    Table 68. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
    Table 69. North America Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (K Units)
    Table 70. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2023)
    Table 71. North America Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (US$ Million)
    Table 72. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2023)
    Table 73. North America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
    Table 74. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2029)
    Table 75. North America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (US$ Million)
    Table 76. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2029)
    Table 77. Europe Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (K Units)
    Table 78. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2023)
    Table 79. Europe Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (US$ Million)
    Table 80. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2023)
    Table 81. Europe Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
    Table 82. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2029)
    Table 83. Europe Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (US$ Million)
    Table 84. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2029)
    Table 85. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2018-2023) & (K Units)
    Table 86. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2018-2023)
    Table 87. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2018-2023) & (US$ Million)
    Table 88. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2018-2023)
    Table 89. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (K Units)
    Table 90. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2024-2029)
    Table 91. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (US$ Million)
    Table 92. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2024-2029)
    Table 93. Latin America Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (K Units)
    Table 94. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2023)
    Table 95. Latin America Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (US$ Million)
    Table 96. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2023)
    Table 97. Latin America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
    Table 98. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2029)
    Table 99. Latin America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (US$ Million)
    Table 100. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2029)
    Table 101. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (K Units)
    Table 102. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2023)
    Table 103. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (US$ Million)
    Table 104. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2023)
    Table 105. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
    Table 106. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2029)
    Table 107. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (US$ Million)
    Table 108. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2029)
    Table 109. PaxVax Company Information
    Table 110. PaxVax Introduction and Business Overview
    Table 111. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 112. PaxVax Cholera Vaccine (Oral Route) Product
    Table 113. PaxVax Recent Development
    Table 114. Sanofi Company Information
    Table 115. Sanofi Introduction and Business Overview
    Table 116. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 117. Sanofi Cholera Vaccine (Oral Route) Product
    Table 118. Sanofi Recent Development
    Table 119. Valneva Company Information
    Table 120. Valneva Introduction and Business Overview
    Table 121. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 122. Valneva Cholera Vaccine (Oral Route) Product
    Table 123. Valneva Recent Development
    Table 124. EuBiologics Company Information
    Table 125. EuBiologics Introduction and Business Overview
    Table 126. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 127. EuBiologics Cholera Vaccine (Oral Route) Product
    Table 128. EuBiologics Recent Development
    Table 129. Key Raw Materials Lists
    Table 130. Raw Materials Key Suppliers Lists
    Table 131. Cholera Vaccine (Oral Route) Market Trends
    Table 132. Cholera Vaccine (Oral Route) Market Drivers
    Table 133. Cholera Vaccine (Oral Route) Market Challenges
    Table 134. Cholera Vaccine (Oral Route) Market Restraints
    Table 135. Cholera Vaccine (Oral Route) Distributors List
    Table 136. Cholera Vaccine (Oral Route) Downstream Customers
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cholera Vaccine (Oral Route) Product Picture
    Figure 2. Global Cholera Vaccine (Oral Route) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Cholera Vaccine (Oral Route) Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Cholera Vaccine (Oral Route) Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Shanchol
    Figure 6. Global Shanchol Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Dukoral
    Figure 8. Global Dukoral Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Vaxchora
    Figure 10. Global Vaxchora Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Product Picture of Others
    Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 13. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2029) & (US$ Million)
    Figure 14. Global Cholera Vaccine (Oral Route) Sales Market Share by Type in 2022 & 2029
    Figure 15. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
    Figure 16. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
    Figure 17. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
    Figure 18. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
    Figure 19. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
    Figure 20. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
    Figure 21. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
    Figure 22. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
    Figure 23. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
    Figure 24. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Cholera Vaccine (Oral Route) Sales in 2022
    Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Cholera Vaccine (Oral Route) Revenue in 2022
    Figure 27. Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 28. Product Picture of Hospital
    Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Product Picture of Research & Academic Laboratories
    Figure 31. Global Research & Academic Laboratories Sales YoY Growth (2018-2029) & (K Units)
    Figure 32. Product Picture of Pharmaceutical & Biotechnology Companies
    Figure 33. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2018-2029) & (K Units)
    Figure 34. Product Picture of Others
    Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 36. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2029) & (US$ Million)
    Figure 37. Global Cholera Vaccine (Oral Route) Sales Market Share by Application in 2022 & 2029
    Figure 38. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
    Figure 39. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
    Figure 40. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
    Figure 41. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
    Figure 42. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
    Figure 43. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
    Figure 44. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
    Figure 45. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
    Figure 46. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
    Figure 47. Key Raw Materials Price
    Figure 48. Cholera Vaccine (Oral Route) Manufacturing Cost Structure
    Figure 49. Cholera Vaccine (Oral Route) Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS